Prostate-specific antigen screening for prostate cancer: benefits for patients with highly aggressive prostate cancer

Lignende værker

• Serum Fucosylated Prostate-specific Antigen (PSA) Improves the Differentiation of Aggressive from Non-aggressive Prostate Cancers
  af: Li, Qing Kay, et al.
  Udgivet: (2015)
• Lifetime Benefits and Harms of Prostate-Specific Antigen–Based Risk-Stratified Screening for Prostate Cancer
  af: Heijnsdijk, Eveline A M, et al.
  Udgivet: (2020)
• Prostate cancer: an emerging threat to the health of aging men in Asia
  af: Zhang, Ling, et al.
  Udgivet: (2011)
• Prostate-specific antigen in screening for prostate cancer.
  af: Mayer, F J, et al.
  Udgivet: (1994)
• What Is the True Mortality Benefit of Prostate-Specific Antigen Screening?
  af: Loeb, Stacy, et al.
  Udgivet: (2010)